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INTRODUCTION 
         Pregnancy is characterized by altered endocrine, metabolic, and 
immunologic milieus. These dramatic alterations result in multiple 
cutaneous changes, both physiologic and pathologic.1 These alterations 
may range from normal cutaneous changes to eruptions that appear to be 
specifically associated with pregnancy. Moreover, pregnancy may modify 
the course of a number of dermatological conditions. Likewise, the 
concerns of the patient may range from cosmetic appearance, to the 
chance of recurrence of the particular problem during a subsequent 
pregnancy, to its potential effects on the fetus in terms of morbidity and 
mortality.2  
               The present study was undertaken to find out the prevalence of the 
physiological and pathological skin changes in pregnancy.  
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REVIEW OF LITERATURE 
ENDOCRINE BACKGROUND 
         Pregnancy is characterized by the advent of a new and unique 
endocrine organ, the placenta. The hormonal changes of pregnancy start 
soon after the fertilized ovum becomes implanted in the endometrium, 
when the developing trophoblast begins to secrete chorionic 
gonadotrophin. This, in turn, stimulates production of estrogen and 
progesterone by the corpus luteum. At about the ninth week of pregnancy 
the fetoplacental unit begins to synthesize pregnenolone and 
progesterone.3 The human placenta synthesizes an enormous amount of 
protein and peptide hormones: lactogen (hPL), adrenocorticotropin 
(ACTH), growth hormone variant (hGH–v), parathyroid hormone – 
related protein (PTH–rp), calcitonin, relaxin, inhibins, activins, and atrial 
natriuretic peptide, thyrotropin – releasing hormone (TrH), gonadotropin 
releasing hormone (GnRH), corticotropin – releasing hormone (CRH), 
somatostatin and growth hormone – releasing hormone (GHRH).4 
          Steroid production rates in nonpregnant and near – term pregnant 
woman are shown in Table 1.4  
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Table 1: 
Steroid production rates in nonpregnant and near – term pregnant woman 
Steroid 
Production rates (mg/24 hrs) 
Nonpregnant Pregnant 
17 β Estradiol  0.1 – 0.6 15 – 20  
Estriol  0.02 – 0.1 50 – 150 
Progesterone  0.1 – 40  250 – 600  
Aldosterone  0.05 – 0.1 0.250 – 0.600  
Deoxycorticosterone  0.05 – 0.5 1 – 12  
Cortisol  10 – 30  10 – 20  
 
 Placental hormones partly facilitate the physiological adaptations 
that occur in pregnancy. The pituitary enlarges and increases its output of 
ACTH, prolactin and gonadotropins. Circulating cortisol rises by a 
decrease in its clearance rate combined with increased cortisol binding 
globulin. The breasts enlarge during pregnancy. 
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          The state of pregnancy is ended by an alteration in the balance of 
the antagonistic actions of estrogen and progesterone. This is probably 
fine tuned by the fetal pituitary adrenal axis and its effect on estrogen 
production.3 
A. PHYSIOLOGICAL SKIN CHANGES RELATED TO 
PREGNANCY  
I. Pigmentation 
 Pigmentary disturbances are the most common of these physiologic 
changes. Hyperpigmentation is seen in upto 90% of pregnant women.1 
The physiology of  hyperpigmentation may be related to elevated serum 
levels of melanocyte stimulating hormone, estrogen, and possibly 
progesterone.5-7 Mild generalized hyperpigmentation is usually seen with 
accentuation of normally hyperpigmented areas such as the areolae, 
nipples, genital skin, axillae and inner thighs. Darkening of the skin 
adjoining the areolae, results in secondary areolae.5 Linea nigra refers to 
the typically reversible darkening of the linea alba, a hypopigmented 
linear patch extending from the pubis symphysis to the xiphoid process of 
the sternum.1  
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 Melasma (chloasma / “mask of pregnancy”) has been reported in 
upto 70% of pregnant women.5,8 This usually develops during the second 
half of pregnancy as irregular, sharply marginated areas of pigmentation 
in a roughly symmetrical pattern either on the forehead and temples, or 
on the central part of the face, or both.3 This type of hyperpigmentation 
results from excessive melanin deposition in the epidermis (70%), dermal 
melanophages (10% - 15%), or both (20%) and can be clinically 
demonstrated by wood’s lamp examination.5 Elevated estrogens, 
progesterone and MSH levels are thought to cause melasma of 
pregnancy.7,9,10 Ultraviolet and visible light may worsen melasma or 
allow it to persist.9,11 In most cases, gestational melasma will resolve 
postpartum. It may recur in subsequent pregnancies.5  
II. HAIR CHANGES  
 Some degree of hirsutism is seen in all women, especially on the 
face, and less often on the arms, legs and back. This is caused by 
endocrine changes of pregnancy and regresses within 6 months 
postpartum.5 Although prolonged anagen phase on the scalp has been 
shown, the anagen to telogen ratio has varied in previous studies.12, 13 
Other changes include a mild frontoparietal recession and diffuse 
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thinning in the later months of pregnancy due to inhibition of anagen 
hairs.5 
III. NAIL CHANGES  
 It includes transverse grooving, brittleness, distal onycholysis, and 
subungual hyperkeratosis. The pathogenesis of nail changes is unclear.5 
IV. GLANDULAR CHANGES  
a) ECCRINE GLAND  
 Increased eccrine function is observed during pregnancy, except on 
the palms where it is diminished. This may contribute to the increased 
incidence of miliaria, hyperhidrosis and dyshidrotic eczema in 
pregnancy.8, 14 The increase in eccrine function has been associated with 
increased thyroid activity.5  
b) APOCRINE GLAND  
 Apocrine activity appears to decrease during pregnancy, which 
may explain the clinical improvement of pre-existing Fox-Fordyce 
disease and hidradenitis suppurativa. The disease may rebound 
postpartum.5 
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c) SEBACEOUS GLAND  
 The rate of sebum secretion tends to increase during pregnancy and 
return to normal after delivery. The rise in sebum secretion during the last 
trimester of pregnancy is due to a powerful sebotrophic stimulus released 
from pituitary.15 Secretion of pituitary factors, such as prolactin, which 
either stimulate sebaceous glands directly or enhance their response to 
androgens.3 The sebaceous glands on the areolae enlarge and appear as 
small brown papules called Montgomery’s glands or tubercles. The effect 
of acne is unpredictable, but in many patients acne develops for the first 
time during pregnancy.5 
V. CONNECTIVE TISSUE CHANGES 
 Striae distensae (Striae gravidarum) develop in upto 90% of 
women during the sixth and seventh months of pregnancy. They appear 
as pink or purple atrophic bands on the abdomen and sometimes on the 
breasts, thighs, and inguinal areas.5 Risk factors include genetic 
predisposition, family history, race.1 Hormonal: adrenocortical hormones, 
estrogen, relaxin and physical factors16 – (stretching secondary to 
increase in the abdominal girth) play a role in the development of the 
striae. There seems to be an association between maternal weight gain, 
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fetal birth weight and the development of striae.5 Striae are commonly 
absent in pregnancy in Ehlers Danlos syndrome.3  
 Molluscum fibrosum gravidarum (skin tags) often appear in the 
second half of pregnancy probably due to hormonal factors.3 
V. VASCULAR CHANGES 
 Vascular changes are thought to be due to sustained high levels of 
circulating estrogen resulting in distension and proliferation of vessels.3 
The changes include spider telangiectases, palmar erythema, nonpitting 
edema, varicosities, vasomotor instability & purpura. Spider 
telangiectases are observed in areas drained by the superior vena cava, 
such as around the eyes. These are seen in 67% of white patients, appear 
between the second & fifth month of pregnancy. Palmar erythema is seen 
as a diffuse pink mottling of the whole palm, or may be confined to the 
thenar and hypothenar eminences.5 5% of pregnant women may develop 
small hemangiomas.3  
 Nonpitting edema of the face, eyelids, and extremities is observed 
in atleast half of all pregnant women. The swelling is most pronounced in 
the early morning and disappears during the course of the day.5 
Varicosities appear in 40% of patients and result from increased venous 
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pressures in the femoral and pelvic vessels caused by the gravid uterus.17 
Vasomotor instability manifested as facial flushing, pallor, hot and cold 
sensations, cutis marmorata of the legs, worsening of preexisting 
raynaud’s phenomenon, dermographism and urticaria are common during 
pregnancy. Purpuric lesions are common on the legs in the second half of 
pregnancy.5 
VI. MUCOSAL CHANGES 
 Hyperemia of the gums is seen in 80 percent or more of pregnant 
women with varying degrees of severity and may be associated with 
gingivitis.18, 19 It develops in third trimester of pregnancy and resolves 
postpartum. Proliferation of capillaries within the hypertrophied gingiva 
results in granuloma gravidarum, pyogenic granuloma or pregnancy 
epulis that appears between the second and fifth months of pregnancy in 
2% of pregnant women. It is seen as a deep – red nodule on the buccal or 
lingual surface of the marginal gingiva.5 Increase in vascularity of lesion 
is due to high estrogen levels.3        
B. DERMATOSES OF PREGNANCY 
 Dermatoses of pregnancy include conditions that occur exclusively 
during pregnancy and results directly from the state of gestation or the 
products of conception.  
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 Currently, two main classification schemes are used. The first, 
proposed by Holmes and Black in 1983, include pemphigoid gestationis, 
polymorphic eruption of pregnancy, prurigo of pregnancy and pruritic 
folliculitis of pregnancy. The second proposed by Shornick in 1998, 
consists of – pemphigoid gestationis, polymorphic eruption of pregnancy, 
prurigo of pregnancy and intrahepatic cholestasis of pregnancy. He 
suggested that pruritic folliculitis and papular dermatitis belong to the 
group of prurigo of pregnancy.20 Moreover, impetigo herpetiformis is 
believed to be a variant of pustular psoriasis that is triggered by 
pregnancy rather than a specific dermatosis of pregnancy.21 
I. INTRAHEPATIC CHOLESTASIS OF PREGNANCY (ICP) 
 Synonyms: Obstetric cholestasis, idiopathic jaundice of pregnancy, 
prurigo gravidarum, pruritus gravidarum, and icterus gravidarum. It was 
first recognized by Svanborg and Ohlsson.1 The incidence varies from 
0.02 to 2.4%.22 It may be subdivided according to those patients with 
hyperbilirubinemia (cholestatic jaundice of pregnancy) and those with 
pruritus and biochemical abnormalities but without hyperbilirubinemia 
(prurigo gravidarum).23,24  
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Pathogenesis 
 i) Estrogens, such as estriol-16αD-glucoronide and estradiol 
17βglucoronide reduces the sodium dependent bile acid uptake into the 
hepatocyte and inhibits basolateral transport proteins.25 Furthermore, the 
increased levels of sulfated progesterone metabolites in the serum may 
saturate the maximal transport capacity of membrane transport proteins of 
the hepatocyte.26 Hormonal etiology is probable because ICP is a disease 
of late pregnancy corresponding  to the period of highest placental 
hormone levels, and spontaneously remits at delivery when hormone 
concentrations normalize, and it recurs during subsequent pregnancies in 
45 to 70 percent of patients.1 ii) Geographical variation and familial 
clustering indicate a genetic predisposition. Candidate genes include 
ABCB4 (multidrug resistance gene 3), ABCB11 and ATP8B1.1 
Heterozygosity for deletion in the multidrug resistance gene 3 was found 
in women with ICP.21 iii)  Reports of higher incidence of ICP with 
reduced selenium levels, hepatitis C virus infection and during winter 
months point towards the role of environmental factors.27 High bile acid 
concentration in the serum and skin causes pruritus and it correlates with 
the intensity of pruritus.22 
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Clinical features 
          It usually manifests in the third trimester. The disorder has no 
primary cutaneous lesions, although secondary excoriations may occur.22 
There is a family history in 50% of cases and an association with multiple 
gestation.21 Patients present with severe pruritus which is more during the 
night time, initially localized over abdomen and extremities and then 
becomes generalized. It may precede jaundice by atleast 4 weeks. 
Fatigue, anorexia, nausea, vomiting and icterus may be seen. Right 
quadrant fullness, dark urine and light colored stools may be present. 
Nowadays anicteric cases with itching should be regarded as merely a 
clinical variant.22 This condition resolves within the first month after 
delivery.21  
Laboratory studies 
 Reveals elevated lactate dehydrogenase, alkaline phosphatase, 
serum glutamic oxaloacetic transaminase (SGOT), serum glutamic 
pyruvic transaminase  (SGPT)  and bilirubin levels. Postprandial bile acid 
levels are regarded as a very sensitive indicator of the disease.22 Cholic 
acid – chenodeoxycholic acid ratio is greater than 1.5.1  
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Maternal complications  
          Postpartum hemorrhage and gallstones.27 
Fetal complications 
 Includes perinatal death, prematurity, low birth weight.27 
Decreased fetal elimination of toxic bile acids may cause vasoconstriction 
of placental chorionic veins and meconium passage.28 Meconium can 
cause acute umbilical vein constriction resulting in asphyxia.21 
Treatment 
 Antipruritics and emollients in mild cases. Cholestyramine and 
ursodeoxycholic acid in severe cases.   
II. PRURITIC URTICARIAL PAPULES AND PLAQUES OF 
PREGNANCY (PUPPP) 
 Synonyms: Polymorphic eruption of pregnancy, Bourne’s toxemic 
rash of pregnancy, Nurse’s late prurigo of pregnancy and toxic erythema 
of pregnancy.  Its incidence ranges between 1 in 130 pregnancies and 1 in 
300 pregnancies. The term PUPPP was coined by Lawley et al (1979).1 
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Pathogenesis 
The pathogenesis of PUPPP is uncertain. A role for sex hormones 
has been suggested.21 A hypothesis suggested that during the aging of 
placenta in the third trimester, a substance is released into the maternal 
circulation that may trigger fibroblast proliferation.5 Several authors 
suggested that rapid abdominal wall distension in primigravidas may 
cause damage to connective tissue in the striae with subsequent 
conversion of nonantigenic molecules to antigenic ones, thus triggering 
an inflammatory process.29-32 There is an association of PUPPP with 
multiple gestation.33 Multiple gestation is associated with excessive 
abdominal distension, it may cause trauma to the skin triggering an 
inflammatory reaction. Furthermore, multiple gestation is associated with 
higher estrogen and progesterone levels.34  
Progesterone has been shown to aggravate the inflammatory 
process at tissue level, and increased progesterone receptor 
immunoreactivity has been detected in skin lesions of PUPPP.35 Increased 
abdominal stretching increases vascular permeability and, hence may 
facilitate the migration of fetal chimeric cells into the maternal skin. 
Familial occurrence has been reported.21 
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Clinical features 
        PUPPP occurs predominantly in primigravidas in the third trimester 
and does not usually recur in subsequent pregnancies. The eruption is 
intensely itchy, polymorphous, showing urticarial and at times, vesicular, 
purpuric, polycyclic or targetoid lesions. The lesions start in the 
abdominal striae and shows periumbilical sparing. The rash then spreads 
over a few days to involve the thighs, buttocks, breasts and arms. The 
face, palms and soles are spared.21 The mean duration of eruption is 6 
weeks. Within an individual patient, lesions are generally 
morphologically uniform. Spontaneous remission within days of delivery 
is the rule.1 
Laboratory investigations 
 Histopathology shows  spongiotic dermatitis with perivascular or 
upper dermal inflammatory cell infiltrate. There may be a striking 
number of eosinophils.5 
Maternal complications    :  Not seen  
Fetal complications    : Not seen  
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Treatment 
 Symptomatic with antipruritics and topical corticosteroids. 
III. PEMPHIGOID GESTATIONIS (PG) 
 This is a rare, self-limiting blistering dermatosis of pregnancy with 
an incidence of 1 in 50,000 pregnancies. The term pemphigoid gestationis 
was proposed in 1982 by Holmes and Black.36  
Pathogenesis 
 Pemphigoid gestationis is an autoimmune disease. The main 
antigenic determinant of PG is collagen XVII (BPAG2 or BP 180), found 
in both the basement membrane zone (BMZ) of skin and the amniotic 
epithelium of the placenta and the umbilical cord.37-39 The antigenic 
epitopes are restricted within the noncollagenous16A  
(NC16A) region.40, 41 It is believed that an aberrant expression of MHC 
class II molecules in the placenta leads to the presentation of this self 
antigen and the triggering of an immune response with antibody 
production. PG antibodies are IgG, mainly IgG1 and IgG3. The 
antibodies cross react with collagen XVII in the skin, form immune 
complexes, activate complement and recruit inflammatory cells. The 
inflammatory mediators released by various cells in the infiltrate induce 
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tissue damage and blister formation.42 The presence of a serum PG 
antibody was first described by Provost and Tomasi known as HG factor. 
The development of  PG is genetically predetermined by the presence of 
MHC class II HLA antigens DR3 and DR4. There is the presence of anti 
HLA antibodies against paternal HLA molecules in virtually all PG 
patients. These antibodies are primarily against HLA class I antigens and 
are separate from circulating anti BMZ antibodies.43 There is a strong 
hormonal association. Estrogen has immune enhancing properties by 
increasing the B cell response, with resultant stimulatory effect on PG.44  
Clinical features 
 PG usually develops in the second or third trimester of pregnancy 
with a mean onset of  21-28 weeks gestation. Onset is with severe 
pruritus followed by erythematous urticarial papules and plaques that 
may become target like or polycyclic. Within days to weeks, progression 
occurs with the formation of clustered tense vesicles and bullae at the 
sites of urticated erythema. Resolution occurs without scarring. In about 
50-90%, the eruption begins on the abdomen periumbilically or within 
the umbilicus and later spreads to involve the whole abdomen, 
extremities, palms and soles. Face and mucous membranes are spared. 
Spontaneous remission after parturition occurs and tends to recur in the 
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subsequent pregnacy. PG has been reported as a paraneoplastic 
presentation in association with hydatidiform mole and 
choriocarcinoma.36  
Laboratory investigations 
 Histopathology shows eosinophilic spongiosis, papillary dermal 
edema, perivascular infiltrate composed of lymphocytes and eosinophils. 
Focal necrosis of basal keratinocytes leads to a subepidermal blister.45 
Direct immunofluorescence shows a heavy linear deposition of C3 and 
IgG along the BMZ of skin, BMZ of amniotic epithelium and in the skin 
of newborns of affected mothers. Indirect immunofluorescence detects 
C3 and IgG in the sera.36 In salt split skin specimens, the antibody binds 
to the roof of the vesicle.5 
Maternal complication: Premature delivery, spontaneous abortion.  
Fetal complication: Small for gestational age46, neonatal disease with 
blisters due to passive transfer of immunoglobulins.47  
Treatment 
         For mild cases - topical corticosteroids and oral antihistamines. 
Severe cases require systemic corticosteroids. 
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IV. PRURIGO OF PREGNANCY (PP) 
 Prurigo of pregnancy comprises the previously described Besnier’s 
prurigo gestationis and Nurse’s early prurigo of pregnancy, papular 
dermatitis of Spangler.5 Incidence is 1 in 300 to 450 pregnancies.21 
Aetiopathogenesis 
 The cause is unknown. The condition may be related to an atopic 
background or ICP or both. Serum IgE levels are elevated which is 
consistent with the theory that PP arises as a result of pruritus gravidarum 
in women with an atopic predisposition.5 
Clinical features 
 Onset is usually in the second or third trimester. Lesions consist of 
pruritic, erythematous, excoriated or crusted papules over the extensor 
surfaces of the extremities, occasionally on the abdomen.48 It resolves 
after delivery. Recurrence during subsequent pregnancy is common.49 
Laboratory investigation 
          Histopathology is nonspecific with chronic inflammatory cell 
infiltrate in upper dermis with occasional epidermal changes.5 
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Maternal complications  : None  
Fetal complications  : None  
Treatment                               :         Symptomatic  
V. PRURITIC FOLLICULITIS OF PREGNANCY (PFP) 
 PFP was described by Zoberman and Farmer in 1981.50 The 
incidence is 1 in 3000 pregnancies.1  
Aetiology  
          Unknown. Wilkinson et al postulated that PFP is related to 
hormonal changes in pregnancy.50 
Clinical features 
 Onset is during the second or third thirmester, and spontaneous 
resolution occurs within 2 to 3 weeks postpartum. Recurrence in 
subsequent pregnancies is uncommon.1 The lesions are pruritic, follicular, 
erythematous, monomorphous papules and pustules over trunk.50  
Laboratory diagnosis 
 Histopathology reveals sterile folliculitis.50 
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Maternal complications    : None  
Fetal complications           : Decreased birth weight  
Treatment                          : Symptomatic  
VI. ATOPIC ERUPTION OF PREGNANCY  
 Ambros – Rudolph  et al have proposed the term atopic eruption of 
pregnancy to denote a new disease complex comprising the previously 
distinct entities PP and PFP as well as eczema in pregnancy.20  The 
features include onset early in pregnancy, a predilection for flexural skin, 
personal and/or family history of atopy, skin lesions with either 
eczematous features (E type AEP) or prurigo type lesions (P type AEP), 
flare up of preexisting atopic dermatitis. Total serum IgE levels may be 
elevated. No specific association with parity or gestation.1 Th2 shift 
associated with pregnancy may favour the exacerbation of atopic 
dermatitis and the manifestation of AEP.20 
C. DERMATOSES MODIFIED BY PREGNANCY 
I. INFECTIONS 
          The increased incidence of certain infections in pregnancy has been 
attributed to the immunosuppressive effects of high serum levels of 
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estrogen. These include a decrease in cell mediated immunity, neutrophil 
function, and activity of natural killer cells, as well as impairment of local 
antibody responses.3  
1. CANDIDIASIS 
 Candida albicans exists as a commensal organism in the vaginal 
mucosa of upto 30% of pregnant woman.1 Higher glycogen content in the 
vaginal environment and estrogen mediated enhanced adherence of 
Candida species to vaginal epithelial cells results in an increased risk of 
symptomatic vaginitis in pregnancy.51 There is vulval pruritus with 
cottage cheese like vaginal discharge and vaginal soreness. Diagnosis is 
confirmed by 10% KOH examination of discharge and culture.  
2. DERMATOPHYTOSIS 
 The fungus invades the stratum corneum possibly aided by warm 
occlusive conditions. Incidence of dermatophytosis during pregnancy is 
similar to that in normal individuals. Typical lesion is annular with 
erythematous scaly margin and central clearing. Diagnosis is by scraping 
and examination in 10% KOH and culture.  
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3. PITYROSPORUM FOLLICULITIS  
 Pityrosporum folliculitis caused by the yeast Malassezia furfur 
occurs with greater frequency in pregnant women.52 The lesions are itchy 
follicular papules over the shoulder and back.  
4. PITYRIASIS VERSICOLOR 
 Pregnancy may have some influence in increasing the susceptibility 
but firm data is lacking.53 Lesions are well defined macules with fine 
branny scaling over seborrhoeic areas. Diagnosis is by scraping 
examination in 10% KOH.  
5. LEPROSY 
 Altered course of leprosy in pregnancy are due to  
i) Metabolic and immunologic changes during pregnancy  
ii) Altered secretion of steroids, as the levels of free cortisol and     
17–hydroxy corticosteroid increase during pregnancy and may 
partly be responsible for the depression of CMI.54   
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Effects of pregnancy on woman with leprosy  
1) Worsening of leprosy  
a) Women already infected with Mycobacterium leprae and 
incubating leprosy are likely to show overt signs of the disease in 
pregnancy.  
b) With established leprosy the disease worsens during pregnancy. 
The changes are due to depression of cell mediated immunity 
during pregnancy. The possible reason is increase in circulating 
thyroxine (T4) during pregnancy.55  
2) Increased incidence of lepra reactions  
a) Type I reaction  
 During pregnancy, downgrading reaction may occur because of 
decreased cell mediated immunity, and is most likely to be manifested in 
the III trimester. In borderline leprosy, upgrading reactions are most 
likely to occur during the puerperium.55  
b) Type 2 reaction (Erythema nodosum leprosum reaction)  
 In lepromatous leprosy, this type of reaction is most likely to occur 
in the III trimester of pregnancy.55  
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Effect on the infant 
1) Low birth weight babies.56 
2)  The infant has higher risk of contracting leprosy from a) the 
mother, if she is an open case b) hidden source of infection in the 
home among relatives c) other patients if born in a leprosarium.55  
6. CONDYLOMA ACUMINATA  
           The prevalence of HPV infection in pregnancy is 5 to 15%.57 The 
genital warts frequently increase in size and number during pregnancy, 
sometimes filling the entire vaginal canal or covering the perineum 
thereby making vaginal delivery or episiotomy difficult.51 Certainly the 
moistness offered by vaginal mucus throughout pregnancy offers ideal 
moist conditions for viral growth. Accelerated viral replication with 
advancing pregnancy has been hypothesized to explain the growth of 
perineal lesion, progression of some to cervical neoplasm, and the 
increased detection of viral DNA from the cervix of pregnant women. 
The lesions regress rapidly after delivery.57 Fetal complications include 
vertical transmission, juvenile laryngeal papillomatosis.  
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7. HERPES SIMPLEX  
 Effect on pregnancy: 
 80% of young women with recently acquired genital herpes 
infection will have an average of 2 to 4 symptomatic recurrences during 
pregnancy. 10% of recurrences in pregnancy are asymptomatic and these 
are more frequently around the perineum than the cervix.57 Primary 
episode during pregnancy may be more severe than in nonpregnant 
women.51 Primary HSV infection leads to grouped vesicular lesions. 
Severe disease may present with gingivostomatitis and vulvovaginitis 
herpetica and dissemination. Risk of neonatal infection is as low as 1% if 
mother acquires genital herpes in first trimester, due to formation of 
protective antibodies, whereas the risk significantly rises to 30 – 50% if 
mother gets infected in last trimester.58 Diagnosis is by viral culture, DIF 
and PCR. ACOG guidelines recommend that caesarian delivery is 
indicated only if the active lesions are present at the time of labour or 
within 4 – 6 hours of rupture of the membranes.51 
Maternal complication: Spontaneous abortion, preterm labour  
Fetal Complication: Intrauterine growth retardation, congenital herpes, 
neonatal herpes – (disseminated / localized / asymptomatic).  
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8. VARICELLA ZOSTER 
 Effect on Pregnancy: 
          Maternal varicella in the first 20 weeks of pregnancy is       
associated with an approximate 2% risk of fetal damage, including skin 
lesions, CNS and ocular defects, and limb hypoplasia, with a 30% 
mortality within the first year of life.59 Maternal zoster in pregnancy is 
not associated with intrauterine infection.60 Zoster in infancy has 
followed maternal varicella, the baby’s primary infection having occurred 
in utero. If the mother has varicella within 4 days before to 2 days after 
delivery, the neonate would have no maternal antibody and is at risk of 
severe varicella with a mortality rate upto 30% in the absence of 
treatment.59  
9. HUMAN IMMUNODEFICIENCY VIRUS  
 The prevalence of HIV infection in pregnant women in India is 
0.3%.61  
i) Effects of pregnancy on HIV  
 Pregnancy does not alter disease progression in asymptomatic 
women and those with early disease, although there may be a more rapid 
progression in women with late stage HIV infection.61 
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ii) Effects of HIV on Pregnancy  
 Spontaneous abortion, ectopic pregnancy, preterm labour, 
stillbirths, low birth weight babies and opportunistic infections.61 
iii)     Mother to child transmission 
         The maximum transmission occurs in late pregnancy and during 
labour. The total risk of transmission is 25 – 40%.The distribution risk is 
as follows: Antepartum: 10 – 15%, intrapartum: 65 – 75%, postpartum: 
10 – 15%. Maternal viral load is the strongest predictor of vertical 
transmission.61  
10. TRICHOMONIASIS 
 Trichomonas is seen in upto 60% of pregnant women but has no 
adverse effects on the fetus.5 Trichomonal vaginitis is characterized by 
yellow vaginal discharge, abnormal odour, vulval pruritus, vulvovaginal 
erythema and colpitis macularis or strawberry cervix. Trichomonads are 
identified in a wet mount of vaginal secretion as flagellated, ovoid, motile 
organism. There is an increased risk of preterm delivery, premature 
rupture of membranes and postpartum fever. Female neonates may 
acquire infection perinatally but this seems to be transient due to maternal 
estrogenic influence.57  
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II. AUTOIMMUNE DISORDERS  
1) SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 
a) Pregnancy impact on the disease.  
 Cutaneous flares are the most common manifestation of SLE in 
pregnancy, followed by arthritis. Painful vasculitic lesions on the 
extremities are the most common skin lesions.5 Worsening of SLE is 
uncommon, if the individual is on immunosuppressive therapy.62 If 
conception occurs during the active stage of SLE, approximately 50% of 
patients will worse during pregnancy, and a few will die or experience 
permanent renal damage.5 Complement activation is associated with 
disease flares during pregnancy, and measures of complement C4 and CH 
50 will decrease during flares.63 
b) Disease impact on pregnancy  
 Clinical remission for 6 months before conception should indicate 
an uncomplicated pregnancy and a livebirth. There is a higher risk of 
premature delivery and fetal loss (abortion in 8% and perinatal mortality 
in 13%). The increased risk of fetal death is due to immune complex 
deposition on the trophoblast basement membrane, or the transplacental 
passage of antiphospholipid antibodies.62 The antiphospholipid antibody 
syndrome present with recurrent miscarriage, thrombosis, livedo 
reticularis, migraine, stroke, and / or thrombocytopenia.64  
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2) SYSTEMIC SCLEROSIS  
a)  Effect of pregnancy on disease 
 Raynaud’s phenomenon usually improves during pregnancy, 
particularly with the increased cardiac output in the second half of 
pregnancy. Gastroesophageal reflux worsens in pregnancy.65, 66 Early 
rapidly progressing diffuse systemic sclerosis are at greatest risk for 
developing serious cardiopulmonary and renal problems during 
pregnancy. The greatest danger in pregnancy is the occurrence of renal 
crisis, secondary to acute onset severe hypertension.65 
b) Effect of disease on pregnancy  
 Preterm births and small full term neonates.65 
3) DERMATOMYOSITIS AND POLYMYOSITIS  
a)      Effect of pregnancy on disease  
 Pregnancy exacerbates the disease in approximately 50% and is 
associated with remission in 20%.67 Classic dermatomyositis (DM) and 
clinically amyopathic dermatomyositis (CADM) can occur for the first 
time in pregnancy. Pregnancy can be a complicating factor for preexisting 
classic DM and CADM. DM presenting in the first trimester of pregnancy 
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worsens maternal health and fetal outcome. The impact of pregnancy on 
DM is thought to be a function of DM disease activity and maternal 
overall health status.68 
b) Effect of disease on pregnancy  
 Women in remission at the time of conception tend to have a more 
favourable outcome.69 Spontaneous abortion, intrauterine growth 
restriction, intrauterine death and premature delivery are common.70 
III. METABOLIC DISORDRS  
1.        PORPHYRIA CUTANEA TARDA  
           Pregnancy and the postpartum period, as well as estrogen-
containing birth control pills, have been reported to exacerbate this 
condition. Morever, intake of iron supplements during pregnancy may 
trigger the appearance of PCT.71 
2. ACRODERMATITIS ENTEROPATHICA 
          Exacerbation during pregnancy appears to be characteristic in some 
patients. Pregnancy may cause a decrease in zinc concentration, however 
this fall in zinc levels may not be entirely due to increased fetal demand 
for zinc, estrogen may also play a role. Spontaneous remission occurs 
postpartum.71 
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IV. CONNECTIVE TISSUE DISEASES 
1) PSEUDOXANTHOMA ELASTICUM (PXE)  
 Disease exacerbates during the course of pregnancy, with the risk 
of exacerbation of cutaneous, vascular and ocular lesions. The main 
complication is gastrointestinal hemorrhage. Worsening of lesions occurs 
in abdomen due to its greatest distension. Other risks include arterial 
hypertension, thromboembolic phenomena and periumbilical perforating 
PXE that seem to increase after multiple gestation.72  
Fetal risk: Abortions, intrauterine growth retardation, risk of genetic 
transmission of the disease to the child.72   
2. EHLERS – DANLOS SYNDROME 
           During pregnancy: The aggravation of the symptoms, mainly in 
articulations, are being reported. The reports of premature births and 
abortions appeared to be a result of cervical insufficiency during the first 
and second trimesters of pregnancy or, also to a spontaneous rupture of 
the fetal membrane. Other complications include hemorrhage, difficult 
cicatrization with dehiscence of the suture, hernias and hematomas. Form 
IV or arterial presents risk of death to the mother that may reach 25%, 
mainly by the rupture of the aorta or uterus. These complications seem to 
be worse during labour and in the early postpartum period. Fetal risk 
includes retarded growth, hernia, luxation and floppy infant syndrome.72 
  
 
33 
3) ANETODERMA 
 During pregnancy: It is likely that some correlation exists 
between the modification of elastic tissue occurring in pregnancy and 
appearance of anetoderma. As antiphospholipid antibodies and systemic 
lupus are associated with anetoderma, it would be advisable to request 
phospholipid antibodies investigation for lupus in pregnant women who 
have developed a picture of primary anetoderma.72 
V.     CUTANEOUS TUMORS  
 The association of pregnancy with hemangioma, 
hemangioendothelioma, and glomus tumor reflects the effect of 
gestational hormones on the vascular structures. Large hemangiomas 
resulting in arteriovenous shunting and high output cardiac failure have 
been reported, these lesions regressed postpartum. New glomangiomas 
may occur in successive pregnancies.5 
 Dermatofibromas, leiomyomas, desmoid tumors and keloids may 
develop or grow rapidly during pregnancy. Neurofibromas may enlarge 
or arise denovo during pregnancy, plexiform neurofibromas may enlarge 
rapidly. This is often associated with massive hemorrhage within the 
tumor. Patients may experience severe vascular complications during 
pregnancy such as hypertension and renal artery rupture. In most cases, a 
partial regression of the lesion occurred postpartum.5  
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 The relationship between pregnancy and malignant melanoma has 
been debated.5 Epidemiologic studies from the USA have failed to show 
significant associations between melanoma and reproductive and other 
hormonal factors in women.3 Grin, Driscoll, and Gromtkels reviewed 
controlled clinical trials to assess the effect of pregnancy on the prognosis 
of melanoma and showed that pregnancy does not influence the 5 year 
survival rates.73 Pregnancy may exacerbate mycosis fungoides and the 
eosinophilic granuloma form of langerhans cell histiocytosis.3 
VI.    MISCELLANEOUS DISORDERS 
1. ACNE VULGARIS  
         Acne may improve during pregnancy, but it is occasionally 
exacerbated during pregnancy. This is particularly the case with acne 
conglobata.74   
 2.     ERYTHEMA MULTIFORME 
 Pregnancy may trigger erythema multiforme. There are reports of 
vaginal stenosis resulting from Stevens - Johnson syndrome occurring in 
pregnancy.74 
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3. URTICARIA 
 Urticaria, particularly physical – pressure type, can occur during 
pregnancy and is often aggravated by pregnancy. It appears mainly on the 
abdomen in the second but more in the third trimester. The cause is 
unclear but precipitating factors may be heat, constricting clothing, or 
even the distension of the abdominal wall.74  
4. PSORIASIS  
 The effects of pregnancy on psoriasis are variable. Psoriasis is 
more likely to improve during pregnancy with relapse postpartum. 
Pregnancy is associated with an increase in the levels of estrogen and 
progesterone, which may play a role in improving psoriasis by promoting 
a state of immune tolerance. It acts in stimulation of B cell mediated 
immunity but suppresses the T cell mediated immunity.74,75 Progesterone 
has also been shown to be the key factor in uterine 
immunosuppression.76,77  
 Clinically, chronic plaque psoriasis is the most common type of 
psoriasis to develop or worsen in pregnancy. In general, chronic plaque 
psoriasis is more likely to improve (40% - 63%) than worsen (14%), due 
to high levels of interleukin 10 in pregnancy.74  
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5. IMPETIGO HERPETIFORMIS 
 It is a variant of generalized pustular psoriasis seen in pregnancy. It 
was first described by Von Hebra in 1872.78 
 Aetiopathogenesis 
 An endocrine cause is suspected. The worsening of pustular 
psoriasis just before menstruation and challenge with progesterone and 
clomiphene produces pustular exacerbations in such patients.3  
Clinical features 
         Onset is usually in the last trimester of pregnancy. It presents as 
symmetric, erythematous patches with grouped pustules at their margins. 
The lesions start in the intertriginous or flexural areas and extend 
centrifugally. Condyloma like lesions may form in the flexures. 
Subungual pustules may cause onycholysis. 5  Tongue, buccal mucosa and 
esophagus may be involved. Constitutional disturbances can occur.3 
Remission is seen postpartum, but recurrence in subsequent pregnancies 
may occur.79  
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Laboratory investigation 
 Leukocytosis, elevated ESR, decreased serum calcium, vitamin D 
and albumin may be found.5 Histopathology shows spongiform 
macropustules of kogoj. Parakeratosis and elongation of rete ridges are 
often found.80 Culture of pustule is sterile. 
Maternal Complications    : Tetany, seizures and delirium.5 
Fetal complications         : Placental insufficiency leads to stillbirth, 
neonatal death or fetal abnormalities.79  
Treatment 
 Systemic corticosteroids are the mainstay of therapy.1 
 6. ERYTHROKERATODERMA VARIABILIS 
 Marked deterioration in erythrokeratoderma variabilis occurred 
during pregnancy in two related women.3 
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AIM OF THE STUDY 
 
1. To study the prevalence of physiological cutaneous changes in 
pregnant women.  
2. To study the prevalence of specific dermatoses of pregnancy.  
3. To study the prevalence of various infective and miscellaneous 
cutaneous diseases in pregnancy.  
4. To correlate the prevalence of the major cutaneous changes and 
diseases in relation to different trimesters of pregnancy and with 
gravidity.  
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MATERIALS AND METHODS 
 
Study design: A cross-sectional study was conducted during the 
period of August 2008 to August 2010. Ethical committee clearance was 
obtained.  
Study sample: Five hundred pregnant women who attended the 
outpatient department of Maternity Hospital, Institute of Obstetrics and 
Gynaecology (Egmore), Chennai were randomly selected, irrespective of 
the duration of pregnancy and gravidity.  
 Informed consent was obtained before clinical examination. 
Detailed history including age, obstetric status, antenatal history, chief 
complaints related to skin, onset  of skin changes / lesions in relation to 
duration of pregnancy, history  of similar illness in previous pregnancies, 
family history of similar lesions, exacerbating factors, associated medical 
and skin diseases, etc were elicited and recorded.  
 Complete dermatological examination was done in all cases to 
study the physiological and pathological changes of skin and its 
appendages. If any specific dermatosis of pregnancy was present, the 
morphology of skin lesions, distribution and the sites involved were 
studied. Relevant systemic examination was carried out. If any 
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preexisting skin disease was present, evidence of exacerbation or 
remission was recorded.  
 Appropriate investigations were done if required to confirm the 
diagnosis. Bedside laboratory procedures like KOH mount, Gram’s stain 
and Tzanck smear were carried out. To confirm diagnosis skin biopsy 
was done in a few cases. In all cases with history of pruritus related to 
specific disorders of pregnancy, liver function tests were done. Screening 
with VDRL and ELISA for HIV was done in all cases. Examination of 
the contact was done in all cases of sexually transmitted disease. Results 
were tabulated and analyzed. Statistical analysis of major cutaneous 
changes between primigravidas and multigravidas, and between various 
trimesters were done by Fisher’s exact test and Chi square test 
respectively.  
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OBSERVATION 
 
A total of 500 pregnant women were studied from August 2008 to 
August 2010. Of these, 291 (58.2%) were primigravidas, 209 (41.8%) 
were multigravidas. Among the multigravidas, 164 (32.8%) were second 
gravida , 39 (7.8%) were third gravida , and 6 (1.2%) were fourth gravid. 
Cases seen in the I trimester were 9 (1.8%), II trimester were 87 (17.4%) 
and III trimester were 404 (80.8%).  98.2% were in the II and III trimester 
of pregnancy.  
 Distribution of cases among various gravidas and trimesters is 
shown in Table 1(Fig 1a&1b). 
Table 1 
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          STUDY POPULATION CHARACTERSTISTICS   
 
 
Fig 1a 
 
Fig 1b 
 
Fig 1c
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Age distribution of the pregnant women in the study group is shown in 
Table 2 (Fig 1c). 
Table 2 
Age distribution of the pregnant women in the study group.(n=500) 
Age Group in Years Total Number Percentage 
16-20 85 17.00% 
21-25 250 50.00% 
26-30 142 28.40% 
31-35 20 4.00% 
36-40 3 0.60% 
 
 The youngest and oldest patients were aged 16 and 39 respectively. 
50% (n=250) of them belonged to the age group 21-25 years.  Majority of 
the cases had type IV and type V skin.  Most of them belonged to lower 
socioeconomic status.  
 The distribution of physiological changes observed during 
pregnancy (n = 500) is shown in Table 3 (Fig 2a).  
          The distribution of physiological changes among various gravidas 
is shown in Fig 2b. 
          The distribution of physiological changes among various trimesters 
is shown in Fig 2c. 
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Table 3 
 
  
 Physiological skin changes were seen in about 474 cases (94.8%). 
Pigmentary changes were noticed in 454 cases (90.8%).  Of the 
pigmentary changes, diffuse pigmentation was noted in 420 cases (84%).  
About 231 cases (46.2%) were primigravidas. About 356 cases (71.2%) 
were observed in III trimester. The pigmentation varied from brown to 
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black in colour. It was seen most commonly in the areolar region (100%) 
followed by genitalia, neck and axillary area. Secondary areolae was seen 
in 420 cases. 
Site of maximum pigmentation among the pregnant women 
(n=420) is shown in Table 4. 
Table 4 
Site of 
pigmentation 
Number of Cases Percentage 
Areola 420 100 
Genitalia 180 42.86 
Axilla 18 4.28 
Neck 23 5.47 
Generalised 120 28.57 
 
 Linea nigra was noticed in 186 cases (37.2%). This was observed 
in 30.4% (n=152) in III trimester, and majority 26.6% (n=133) were 
primigravidas. This was seen as hyperpigmented midline streak extending 
from the pubis symphysis to the xiphoid process of the sternum (Fig 3).  
          Melasma was seen in 130 cases (26%). This was noticed in the III 
trimester in 98 cases (19.6%), and most of them (n=97, 19.4%) were 
primigravidas. The cheeks and nose were the most commonly affected 
sites  (Fig 4). Other sites involved were the forehead and chin.  
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Fig 3. Linea nigra in a primigravida in III trimester 
 
Fig  4. Melasma in a second gravida in III trimester 
  
 
45 
 No increase in the number and size of melanocytic naevi was 
observed during the course of pregnancy in any case in this study.  
Table 5 
Statistical analysis of association between pigmentary  
changes and gravidity. 
 
Pigmentary changes Present Absent Test of significance 
Primigravida 254 (50.8%) 37 (7.4%) P = 0.001 
Multigravida 200 (40%) 9(1.8%) 
 
 
 50.8% of primigravida and 40% of multigravida had pigmentary 
changes, this difference in proportion of pigmentary changes between 
primigravida and multigravida was statistically significant (p=0.001) by 
Fisher’s exact test.        
Table 6 
Statistical analysis of association between pigmentary 
changes and various trimesters. 
Pigmentary changes Present Absent Test of significance 
Trimester 
I 7 (1.4%) 2 (0.4%) 
P = 0.349 II 78 (15.6%) 9(1.8%) 
III 369 (73.8%) 35 (7%) 
 
 No statistically significant difference in proportion of pigmentary 
changes between various trimesters was observed in our study by Chi 
square test (p=0.349). 
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Vascular changes were seen in 118 cases (23.6%).  Gingival 
hyperplasia was seen in 8 cases (1.6%), all were primigravidas seen in III 
trimester (Fig 5). Vulval varicosities were observed in 26 cases (5.2%). 
All were seen in III trimester. Majority of them were third gravida (n=13, 
2.6%) (Fig 6).  Nonpitting pedal edema was noticed in 82 cases (16.4%). 
Most of them were primigravidas (n=58, 11.6%).  All were seen in III 
trimester (Fig 7). Abdominal wall edema was noticed in 2 cases (0.4%), 
both of them were second gravida seen in III trimester (Fig 8). 
Table 7   
 
Statistical analysis of association between vascular  
changes and gravidity. 
 
Vascular changes Present Absent Test of significance 
Primigravida 73(14.6%) 218 (43.6%) 
P = 0.3935 
Multigravida 45 (9%) 164 (32.8%) 
 
 
 By Fisher’s exact test, the difference in proportion of vascular 
changes between primigravida and multigravida was not statistically 
significant (p=0.3935). 
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Fig 5. Gingival hyperplasia in a primigravida in III trimester 
 
 
Fig 6. Vulval varicosity in a third gravida in III trimester 
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Fig 7. Nonpitting pedal edema in a 
primigravida in III trimester 
Fig 8. Abdominal wall edema in a 
second gravida in III trimester 
  
 
 
 
 
 
Fig 9. Striae gravidarum in a primigravida in III trimester 
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Table 8 
Statistical analysis of association between vascular changes and 
various trimesters. 
 
 
Pigmentary changes Present Absent Test of significance 
Trimester 
I 0 9 (1.8%) 
P < 0.0001 II 0 87(17.4%) 
III 118 (23.6%) 286 (57.2%) 
 
 
The difference in proportion of vascular changes between various 
trimesters was statistically significant (p < 0.0001) by Chi square test. 
Connective tissue changes were observed in 402 cases (80.4%).  Of 
these, striae gravidarum was seen in 398 cases (79.6%).  138 cases had 
striae due to previous pregnancies. 66% (n=330) were in III trimester.  
40.8% (n=204) were primigravidas and 38.8% (n=194) were 
multigravidas. Among the multigravidas, 152 cases (30.4%) were second 
gravida , 38 cases (7.6%) were third gravida and 4 cases (0.8%) were 
fourth gravid. The abdomen was the most common site involved  
(Fig 9). 
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Table 9 
Statistical analysis of association between striae gravidarum  
and gravidity. 
 
Striae  
gravidarum 
Present Absent Test of significance 
Primigravida 204 (40.8%) 87 (17.4%) 
P < 0.0001 
Multigravida 194 (38.8%) 15 (3%) 
 
 
 The difference in proportion of striae gravidarum between 
primigravida and multigravida was statistically significant (p<0.0001) by 
Fisher’s exact test. 
Table 10 
Statistical analysis of association between striae gravidarum  
and various trimesters. 
 
Striae  
gravidarum 
Present Absent Test of significance 
Trimester 
I 4 (0.8%) 5 (1%) 
P = 0.007 II 64 (12.8%) 23 (4.6%) 
III 330 (66%) 74 (14.8%) 
 
 
Between various trimesters, statistically significant difference 
(p=0.007) in proportion of  striae gravidarum was observed by Chi square 
test.  
Acrochordons was observed in 4 cases (0.8%) and 2 cases (0.4%) 
were in III trimester (Fig 10). 3 cases (0.6%) were second gravida and 1 
case (0.2%) – primigravida. 
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Hirsutism was seen in 3 cases (0.6%).  2 cases (0.4%) were 
primigravidas seen in III trimester. Diffuse hair loss was seen in 5 cases 
(1%). All were in III trimester.  
 Nail changes were noted in 4 cases (0.8%). They included 
brittleness and leukonychia.  
Miliaria was observed in 68 cases (13.6%). The lesions were 
distributed over the trunk, neck and face (Fig 11). 55 cases (11%) were in 
III trimester.  Gravida 1 constituted 25 cases (5%), gravida 2 – 37 cases 
(7.4%), gravida 3 – 6 cases (1.2%).  
 The specific dermatoses of pregnancy were observed in 70 cases 
(14%) exclusively in III trimester in this study, the distribution of cases 
were shown in Table 11 (Fig 12a). 
Table 11 
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Fig 10. Acrochordons and acanthosis nigricans in a second gravida  
in III trimester 
 
Fig 11. Miliaria rubra in a second gravida in III trimester 
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The distribution of specific dermatoses of pregnancy among 
various gravidas is shown in Fig 12b.  
The distribution of specific dermatoses of pregnancy among 
various trimesters is shown in Fig 12c.  
Table 12 
 
Statistical analysis of association between specific  
dermatoses and gravidity. 
 
Specific dermatoses Present Absent Test of significance 
Primigravida 58(11.6%) 233(46.6%) 
P < 0.0001 
Multigravida 12 (2.4%) 197 (39.4%) 
 
 
 By Fisher’s exact test, the difference in proportion of specific 
dermatoses between primigravida and multigravida was statistically 
significant (p<0.0001). 
Table 13 
 
Statistical analysis of association between specific  
dermatoses and various trimesters. 
 
Specific dermatoses Present Absent Test of significance 
Trimester 
I 0  9 (1.8%) 
P < 0.0001 II 0 87 (17.4%) 
III 70 (14%) 334 (66.8%) 
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By Chi square test, the difference in proportion of specific 
dermatoses between various trimesters was statistically significant  
(p< 0.0001). 
Pruritus gravidarum was the most common disease encountered 
(n=52, 10.4%). Of those affected, 44 (8.8%) were primigravidas and 8 
were gravida 2 (1.6%). All had single gestation pregnancies. Two of the 8 
multigravidas reported identical symptoms in previous pregnancies. All 
the cases presented exclusively in III trimester. All had sudden onset of 
severe pruritus which started initially in the abdomen and later became 
generalized, which was followed by secondary skin lesions, namely 
excoriations and excoriated papules. None of these cases had clinical 
jaundice. The liver function tests were normal in all except two patients 
who had elevated alkaline phosphatase levels.   
Pruritic urticarial papules and plaques of pregnancy were observed 
in 8 cases (1.6%). Majority were primigravidas (n=7, 1.4%) and 1(0.2%) 
was a multigravida (G2).  All had single gestation pregnancy. Skin 
lesions occurred in all cases in III trimester. The pruritic eruption started 
characteristically on the lower abdomen, particularly within or adjacent to 
the striae distensae in all cases (Fig 13a, 13b&13c). With disease 
progression, the eruption was seen to involve other parts of the body also 
(Fig 14&15). Vast majority of patients had erythematous urticarial 
papules and plaques.  
  
 
52 
 
 
     
 
Fig 13a      Fig 13b 
 
 
 
 
 
 
Fig 13c 
Urticarial papules over striae in primigravida with PUPPP in  
III trimester (Fig 13a, Fig 13b&13c) 
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Fig 14. Urticarial papules over legs in a primigravida with PUPPP  
in III trimester 
 
 
Fig 15. Urticarial papules and plaques over thighs in a primigravida  
with PUPPP in III trimester
  
 
52 
Prurigo of pregnancy was seen in 9 cases (1.8%). 6 (1.2%) were 
primigravidas and 3 (0.6%) were multigravidas. All had onset of skin 
lesions in III trimester. All patients had single gestation pregnancies and 
none of the multiparous women reported similar rashes in previous 
pregnancies. The eruption was typically composed of itchy 
hyperpigmented papules and excoriations which first appeared over 
extensor surfaces of limbs (Fig 16), and with disease progression, 
involved the abdomen and trunk (Fig 17&18). 
Pruritic folliculitis was observed in 1 case (0.2%), which was seen 
in a primigravida in III trimester, as itchy erythematous follicular papules 
over the abdomen (Fig 19). 
  The face and mucous membrane were spared in all the specific 
dermatoses. No case of pemphigoid gestationis was observed in this 
study. 
            Infections were observed in 30.8% (n=154) of cases, which is 
shown in Table 14 (Fig 20a). 
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Fig 16. Excoriated papules and nodules over extensor surface of legs in a 
primigravida with prurigo of pregnancy in III trimester 
 
 
 
 
Fig 17. Excoriated papules and nodules over abdomen in a primigravida 
with prurigo of pregnancy in III trimester 
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Fig 18. Excoriated papules and nodules over forearms in a primigravida 
with prurigo of pregnancy in III trimester 
 
 
 
 
Fig 19. Follicular papule over abdomen in a primigravida with pruritic 
folliculitis in III trimester
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Table 14 
 
 The distribution of infections among various gravidas is shown in 
Fig 20b.  
 The distribution of infections among various trimesters is shown in 
Fig 20c.  
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Table 15 
Statistical analysis of association between infections and gravidity.  
Infections Present Absent 
Test of 
significance 
Primigravida 77 (15.4%) 214 (42.8%) 
P = 0.0142 
Multigravida 77 (15.4%) 132 (26.4%) 
 
Fisher’s exact test showed statistically significant difference in 
proportion of infections between primigravida and multigravida 
(p=0.0142). 
Table 16 
 
Statistical analysis of association between infections  
and various trimesters. 
 
 
 
 
 
Infections Present Absent 
Test of 
significance 
Trimester 
I 3 (0.6%)  6 (1.2%) 
P = 0.059 II 36 (7.2%) 51 (10.2%) 
III 115 (23%) 289 (57.8%) 
 
Chi square test showed no statistically significant difference in 
proportion of infections between various trimesters (p=0.059). 
Bacterial infections were observed in 1.2% (n=6). Of the bacterial 
infections, furunculosis was observed in 4 primigravidas (0.8%). They 
were in III trimester (Fig 21). Out of these 4 cases, one had gestational 
diabetes.  
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 Hansen disease was seen in 2 cases (0.4%). One was a 
primigravida in III trimester who presented as lepromatous leprosy with 
healed trophic ulcer (Fig 22a&22b). Other was a primigravida in I 
trimester who presented as borderline tuberculoid leprosy.  
 Viral infections were observed in 4% (n=20). Of the viral 
infections, wart was seen in 8 cases (1.6%). Condyloma acuminata was 
noted in 5 cases (1%), all were primigravidas in III trimester. One of 
them had verrucous pinkish exuberant growth occupying the introitus 
(Fig 23). The other women had pinkish and verrucous papules over the 
labia minora and labia majora. 3 cases (0.6%) of verruca vulgaris was 
noticed. Of these, 2 cases were primigravidas and 1 was a second gravida 
(Fig 24). 
 Herpes simplex infection was noted in 5 cases (1%). Of these, 
herpes labialis (HSV 1) was seen in 3 cases (0.6%). They presented with 
multiple grouped vesicles and erosions around the mouth (Fig 25). HSV 
II (genital herpes) was seen in 2 cases (0.4%), who presented with 
multiple painful erosions and ulcers over the labia majora and minora 
(Fig 26). Tzanck smear showed multinucleated giant cells. Herpes zoster 
was observed in 1.2% (n=6) of cases (Fig 27a&27b). 
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Fig 21. Furunculosis over face and neck in a primigravida  
in III trimester 
 
 
 
        
Fig 22a Fig 22b 
Fig 22a&22b. Infiltration over forehead, cheeks and chin in a 
primigravida with lepromatous leprosy in III trimester 
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Fig 23. Condyloma acuminata in a primigravida in III trimester 
 
Fig 24. Verruca vulgaris in a primigravida in III trimester 
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Fig 25. Herpes labialis in a primigravida in III trimester 
 
 
Fig 26. Genital herpes over labia minora and majora in a second gravida 
in I trimester 
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Fig 27a 
 
 
 
Fig 27b 
Fig 27a&27b. Herpes zoster involving T4 dermatome in a primigravida 
in III trimester
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 HIV was noticed in 1 case (0.2%) She was a primigravida seen in 
II trimester. Male partner was also infected with HIV. She had 
exaggerated insect bite allergy.  
 Fungal infections were observed in 23.8% (n=119). Of the fungal 
infections, pityriasis versicolor was the commonest (n = 53, 10.6%). It 
was seen in 32 cases (6.4%) of primigravidas, 16 cases (3.2%) second 
gravida and 5 cases (1%) of third gravida. Most of them were in III 
trimester (n=35, 7%). It was seen as hypopigmented fine scaly macules 
and patches distributed over face, chest, and upper back, few were 
perifollicular (Fig 28). Scraping and 10% potassium hydroxide mount 
showed short, angulated, hyaline, nonseptate hyphae and blastospores.   
 Candidiasis was observed in 40 cases (8%). Most of them were in 
third trimester (n=35, 7%). Candidal vulvovaginitis and intertrigo (Fig 
29a) was observed in 34 cases (6.8%). Oral candidiasis (Fig 29b) was 
seen in 6 cases (1.2%). Scraping and 10% potassium hydroxide mount 
showed pseudohyphae with blastospores. 13 of them had associated 
gestational diabetes.   
           Dermatophytosis was observed in 26 cases (5.2%). Most of them 
were in III trimester (n = 19, 3.8%). 12 were primigravidas (2.4%), 10 
were second gravida (2%), 2 were third gravida (0.4%) and 2 were fourth  
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Fig 28. Pityriasis versicolor in a primigravida in II trimester 
 
 
 
Fig 29a. Candidal vulvovaginitis and intertrigo in a second gravida  
in III trimester 
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Fig 29b. Oral candidiasis with angular cheilitis in a primigravida 
in III trimester 
 
 
 
Fig 30. Tinea corporis in a second gravida in III trimester
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gravida (0.4%). The clinical types seen were tinea corporis, tinea cruris, 
tinea axillaris and tinea glutealis. The lesions were annular with 
erythematous, scaly borders and few papules in the margins with central 
clearance (Fig 30). Scraping and 10% potassium hydroxide mount 
showed branching, septate, hyaline hyphae with arthrospores.  
 Of the protozoal diseases, Trichomoniasis occurred in 8 cases 
(1.6%). It was observed to be more common in the III trimester (n = 5, 
1%) and in second gravida (n=6, 1.2%), who presented with pruritic 
vaginal discharge. Wet film showed Trichomonas vaginalis organisms 
with characteristic motility.  
 Scabies was seen in 1 case (0.2%) in a second gravida in II 
trimester. She had itchy papules over the web spaces of the hands, thighs 
and genitalia.  
 The distribution of miscellaneous dermatoses observed in 
pregnancy is shown in Table 17 (Fig 31a).  
          The distribution of miscellaneous dermatoses observed in 
pregnancy among various gravidas is shown in Fig 31b.  
 The distribution of miscellaneous dermatoses observed in 
pregnancy among various trimesters is shown in Fig 31c.  
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Table 17 
 
          Acne vulgaris was observed in 52 cases (10.4%). Most of them 
were primigravidas (n = 32, 6.4%), 19 (3.8%) were second gravida and 1 
(0.2%) was a third gravida. Most of them were seen in third trimester 
(n=37, 7.4%). 32 cases (6.4%) had onset of acne during pregnancy and 20 
cases (4%) had exacerbation of previous acne lesions (Fig 32).  
Insect bite allergy was observed in 30 cases (6%), most commonly 
seen in III trimester (n=25, 5%).11 cases (2.2%) were primigravidas, 14 
cases (2.8%) were second gravida, and 5 cases (1%) were third gravida. 
The lesions were itchy hyperpigmented papules and excoriations 
distributed mainly below the elbows and the knees.  
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Acanthosis nigricans was observed in 2 cases (0.4%) in III 
trimester. One was a second gravida (n = 1, 0. 2%) (Fig10) and other a 
third gravida (n = 1, 0.2%), both of them were obese, presented with 
hyperpigmented velvety plaques over the neck.  
Pityriasis rosea was observed in 2 cases (0.4%) in I trimester. One 
was a primigravida and other a second gravida, who presented with 
multiple erythematous patches and plaques with collarette of fine scales 
distributed over back, chest and abdomen (Fig 33).  
Psoriasis was seen in 1 case (0.2%) in I trimester in a second 
gravida. She presented as chronic plaque type with well defined plaques 
covered with silvery scales over the extensor surface of arm, forearm, 
thighs, legs, abdomen and back. Auspitz sign was positive (Fig 34).  
Impetigo herpetiformis (n = 1, 0.2%) occurred in a fourth gravida 
in III trimester. The patient was a known case of psoriasis vulgaris who 
presented as generalized pustular psoriasis during pregnancy, with lakes 
of pus over abdomen, thighs, legs, arms, forearms, back and 
intertriginous areas (Fig 35). 
Urticaria was seen in 1 case (0.2%), the urticarial wheals developed 
in II trimester over the extremities, abdomen and chest.  
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Fig 32. Acne vulgaris in a primigravida in III trimester 
 
 
 
 
Fig 33. Pityriasis rosea over back in a primigravida in I trimester 
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Fig 34. Psoriasis vulgaris in a second gravida in I trimester 
 
 
 
Fig 35. Lakes of pus and pustules over abdomen in a fourth gravida with 
impetigo herpetiformis in III trimester
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 Exacerbation of neurofibromatosis was seen in 2 cases (n = 2, 
0.4%). Both were primigravidas, with increased number of cutaneous 
neurofibromas during pregnancy, particularly in III trimester (Fig 36).  
         Antiphospholipid antibody syndrome was observed in 2 cases 
(0.4%). Both of them were third gravida seen in II trimester. None of 
them had cutaneous features but had lupus anticoagulant antibodies. 3 
known cases (0.6%) of systemic lupus erythematosus were seen in II 
trimester. 1- primigravida, 1- second gravida and 1- third gravida. All had 
cutaneous flares and arthritis (Fig 37a&37b).   
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Fig 36. Neurofibromatosis in a primigravida in III trimester 
 
 
 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
Fig  37a Fig  37b 
 
Fig 37a&37b. Maculopapular rash in a primigravida with systemic  
lupus erythematosus in II trimester
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DISCUSSION 
Pregnancy produces many cutaneous changes, some of which are 
specifically related to pregnancy (dermatoses of pregnancy), some are 
modifiable by pregnancy and others that are more common are named 
physiologic. These physiological skin changes, usually do not impair the 
health of the mother or the fetus. Nevertheless, some can be cosmetically 
significant and of importance to the dermatologist.  
 In our study, majority of the pregnant women had physiological 
skin changes (n = 474, 94.8%). Hyperpigmentation is common during 
pregnancy and may be seen in upto 90% of pregnant women.1 Muzaffar et 
al.82 observed pigmentary changes in 90.7% of cases. Kumari et al.2 
reported hyperpigmentation  in 91.4% of pregnant women.  In this study 
we observed pigmentary changes in 90.8% which is consistent with 
above mentioned studies. The most common pigmentary change was 
diffuse pigmentation seen in 420 cases (84%). The sites of increased 
pigmentation observed in the order of frequency were areolae, genitalia, 
neck and axilla. Secondary areolae developed in all 420 cases (100%). 
Linea nigra was seen in 186 cases (37.2%). 
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 Melasma has been reported to occur in upto 70% of pregnant 
women.5,8 Muzaffar et al.82 found melasma to be present in 46.4% of their 
cases and Raj et al.83 observed melasma in 8.8% of cases, whereas in this 
study, melasma was seen in 26% (n = 130) of cases. Cheeks and nose 
were the common sites involved. Martin and Leal khouri84 reported an 
onset of melasma during II trimester, whereas in this study, the onset of 
melasma in most (n = 98, 19.6%) of the cases were in early third 
trimester.  
 Type B pigmentary demarcation lines are known to appear for the 
first time during pregnancy2,which was not observed in our study. This 
may be due to the fact that pigmentary changes are more discernible in 
fair skinned individuals.   
 Higher proportion of pigmentary changes was observed in 
primigravidas (50.8%), which was stastically significant (p=0.001).  
Muzaffar et al.82 reported vascular changes in 34.2% of cases, with 
non-pitting pedal edema in 48.5% of cases. In our study, vascular changes 
were noticed in 23.6% (n = 118) of cases, with non-pitting pedal edema 
in 16.4% of cases.  
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Varicosities were reported in 40% of patients.17 Raj et al.83 reported 
varicosities in 5.3%. In this study, vulval varicosities were observed in 
5.2% (n=26) of cases, with the onset being in III trimester. 
During pregnancy, gingival hyperplasia was seen in 80%, with the 
onset in III trimester.18, 19 In a study by Muzaffar et al.82 16.4% of cases 
had gingival edema and redness. Kumari et al.2 reported gingivitis in 
1.5% of pregnant women. In this study, gingivitis not attributable to bad 
oral hygiene was seen in 1.6% (n = 8) of cases. Raj et al.83 had seen 3 
cases of pyogenic granuloma in their study. None of the pregnant women 
in our study had pyogenic granuloma. 
In III trimester, higher proportion of vascular changes was 
observed (23.6%), which was statistically significant (p<0.0001).  
          Kumari et al.2, Muzaffar et al.82, Raj et al.83 and Shivakumar and 
Madhavamurthy81 reported striae gravidarum in 79.7%, 77.1%, 75.4% 
and 66.47% respectively. In our study, the prevalence of striae 
gravidarum was found to be 79.6% (n = 398) of cases, with the onset 
being more common during third trimester (n = 330, 66%), which was 
statistically significant (p=0.007). In primigravidas, higher proportion of 
striae gravidarum was observed (40.8%), which was statistically 
significant (p<0.0001).         
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Acrochordons was seen in upto 0.8% of individuals and are 
probably due to hormonal factors.3  
 The changes in hair growth such as hirsutism (0.6%), telogen 
effluvium (1%) are in accordance with other studies.2  
 Miliaria was observed in 13.6% (n = 68) of cases. This may be due 
to the increased eccrine function during pregnancy.8,14  
           The nail changes observed were brittleness and leukonychia in 
0.8% of cases, which is consistent with other studies.2  
          Specific dermatoses of pregnancy are almost always associated 
with pruritus and an eruption of variable severity. Kumari et al.2 reported 
22 (3.6%) cases of specific dermatoses of pregnancy. Raj et al.83 reported 
specific dermatoses in 16.3% of cases. The specific dermatoses of 
pregnancy observed in our study was 14% (n = 70) and was seen 
exclusively in third trimester, which was statistically significant 
(p<0.0001). Higher proportion of specific dermatoses was observed in 
primigravida (11.6%), which was statistically significant (p<0.0001).  
 In literature, pruritus gravidarum is seen in the third trimester of 
pregnancy in 70% of cases5, with the incidence varying from 0.02% to 
2.4% of pregnancies.22 Shivakumar and Madhavamurthy81 reported 
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3.52% and Raj et al.83 reported 0.1% of cases of pruritus gravidarum.  In 
our study, pruritus gravidarum was the most common specific dermatoses 
encountered (n =52, 10.4%). Of those affected, 44 (8.3%) were 
primigravidas, with the onset being in III trimester. The onset during third 
trimester is consistent with other studies.5, 81, 83   
         The incidence of pruritic urticarial papules and plaques of 
pregnancy ranges between 1 in 130 pregnancies and 1 in 300 
pregnancies.1 Shivakumar and Madhavamurthy81 reported PUPPP in 
2.35% of cases. Raj et al.83 reported in 0.2% of cases. Kumari et al.2 
reported the occurrence of PUPPP in 14/22 cases. In our study, PUPPP 
was observed in 8 cases (8/70, 1.6%). Majority were primigravidas (n=7, 
1.4%). All had single gestation pregnancy. No association with multiple 
gestation was observed in our study. The characteristic eruption occurred 
in all patients in III trimester.  The parity (primigravida) and the onset in 
III trimester is consistent with other studies.2, 81, 85-87 Furthermore, the 
onset in III trimester and the primigravida being affected more was 
supported by the hypothesis that rapid abdominal wall distension in 
primigravidas may cause damage to connective tissue in the striae with 
conversion of nonantigenic molecules to antigenic ones, triggering an 
inflammatory response.21, 29-32   
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Shivakumar and Madhavamurthy81, Raj et al.83 and Kumari et al.2 
reported prurigo of pregnancy in 9.41%, 1.2% and 1/22 cases 
respectively. In this study, prurigo of pregnancy was seen in 1.8% (n=9) 
of cases. 
Pruritic folliculitis of pregnancy was noticed in 0.2% (n=1), which 
is consistent with other studies.2 
          The incidence of pemphigoid gestationis is 1 in 50,000 
pregnancies.36 None of the patients in this study had pemphigoid 
gestationis. 
         The infections observed in our study was 30.8% (n=154). 
Statistically significant proportion of infections was observed in 
multigravidas (15.4%, p=0.0142).  
           The most common infection observed in our study was fungal 
infection, seen in 23.8% (n=119).  Pityriasis versicolor was seen in 
10.60% (n=53) of cases, the high prevalence of pityriasis versicolor may 
be attributed to warm humid environment in addition to the influence of 
pregnancy.53 
Shivakumar and Madhavamurthy81 reported candidiasis in 21.78% 
and Raj et al.83 in 2.9%. In our study, Candidiasis was seen in 8% (n=40) 
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of cases. Candidal vulvovaginitis and intertrigo was observed in 34 cases 
(6.8%) and oral candidiasis in 6 patients (1.2%).  It may be due to the 
higher glycogen content in the vaginal environment and estrogen 
mediated enhanced adherence of candida species to vaginal epithelial 
cells in pregnancy.51   
In this study dermatophytosis was seen in 5.2% (n=26) of cases.  
Bacterial infections observed in our study were 1.2%. Of the 
bacterial infections, furunculosis was seen in 0.8% of cases (n=4).  One 
of them had gestational diabetes. 
Hansen’s disease was noticed in 0.4% (n=2) of cases.  One was 
lepromatous leprosy and the  other was borderline tuberculoid leprosy. 
Both the patients noticed the disease onset during pregnancy, which 
clearly shows the worsening of the disease during pregnancy, as 
described in literature.55 
Viral infections observed in our study were 4%. Shivakumar and 
Madhavamurthy81 reported condyloma acuminata in 4.70% of cases. In 
this study, warts were seen in 1.6% of cases (n=8), with 5 cases of 
condyloma acuminata (1%) and 3 cases (0.6%) of verruca vulgaris.  
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Condyloma acuminata in one of the patient had rapid growth during the 
course of pregnancy, which is in accordance with literature.57   
Herpes labialis and genital herpes were observed in 0.6% and 0.4% 
respectively in our study.  This is consistent with other reports.81 
Herpes zoster was observed in 1.2% (n=6), as pregnancy being an 
immunosuppressed state may act as a trigger factor for the development 
of herpes zoster. 
The prevalence of HIV infection in pregnant women in India is 
about 0.3%.61 In our study, HIV was seen in 0.2% (n=1) of cases. 
Trichomoniasis is seen in upto 60% of pregnant women.5 
Shivakumar and Madhavamurthy81 reported 8.23% of cases of 
trichomoniasis. In our study, it was observed in 1.6% (n=8) of 
individuals. Scabies infestation was seen in 0.2% (n=1) in this study. 
          Acne vulgaris was observed in 10.4% (n=52) of individuals. 6.4% 
had onset of acne first during pregnancy and 4% had exacerbation of 
previous acne lesions, with most of the cases seen in III trimester (7.4%), 
as described in literature, this may be due to the increased sebum 
secretion rate due to a sebotrophic factor released from pituitary during 
the last trimester.15 
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Insect bite allergy was observed in 6% (n=30). This exaggerated 
response to insect bite allergy in pregnancy needs further study. 
Acanthosis nigricans was seen in 0.4% (n=2) of cases.  This may 
be a result of obesity. 
Pityriasis rosea was seen in 0.4% (n=2). 
Psoriasis was observed in 1 individual (0.2%), without any 
worsening during pregnancy, which is consistent with literature.74 
           Impetigo herpetiformis was observed in 0.2% of cases (n=1) 
during III trimester.  The onset of the disease is consistent with other 
studies.5 The patient was a known case of psoriasis vulgaris, who 
presented as generalized pustular psoriasis during pregnancy with typical 
features.  As described in literature, this may be due to the hormonal 
influence of pregnancy over the disease, as an endocrine cause is being 
suspected for impetigo herpetiformis.3  
         Urticaria was seen in 0.2%, which needs further study.  
          Exacerbation of neurofibromatosis with increased number of 
cutaneous neurofibromas during pregnancy in III trimester was seen in 2 
cases (0.4%).  This is in accordance with literature, that neurofibroma 
may enlarge or arise denovo during pregnancy.5 
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          Antiphospholipid antibody syndrome was noticed in 2 cases 
(0.4%). 3 cases (0.6%) of systemic lupus erythematosus was observed 
with cutaneous flares and arthritis, which is consistent with literature.63  
 
In this study, the prevalence of physiological skin changes was 
much higher than specific dermatoses, stressing the fact that in most 
instances, the skin problems during pregnancy needs only reassurance. 
But meticulous observation and examination should be done, as 
pregnancy can influence many dermatological diseases and infections. 
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CONCLUSION 
1. In this study, the prevalence of physiological skin changes in 
pregnant women was 94.8%, with pigmentary changes being the 
most common (90.8%), followed by striae gravidarum (79.6%), 
vascular changes (23.6%), miliaria (13.6%), hair changes (1.6%) 
and nail changes (0.8%). 
2. The prevalence of specific dermatoses of pregnancy was 14%. 
Pruritus gravidarum was the most common disease encountered 
(10.4%), followed by prurigo of pregnancy (1.8%), pruritic 
urticarial papules and plaques of pregnancy (1.6%) and pruritic 
folliculitis of pregnancy (0.2%). 
3. The prevalence of infections was 30.8%. The most common 
infection observed in our study was fungal infection (23.8%), 
followed by viral (4%) and bacterial (1.2%) infections. Pityriasis 
versicolor was the most common fungal infection observed 
(10.6%), followed by candidiasis (8%). 
4. The miscellaneous dermatoses observed in this study in the order 
of prevalence were acne vulgaris (10.4%), insect bite allergy (6%), 
acanthosis nigricans (0.4%), pityriasis rosea (0.4%), 
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antiphospholipid antibody syndrome (0.4%), psoriasis (0.2%), 
impetigo herpetiformis (0.2%) and urticaria (0.2%). Exacerbation 
of systemic lupus erythematosus and neurofibromatosis during 
pregnancy was observed in 0.6% and 0.4% respectively. 
5. Compared to multigravidas, primigravidas had a statistically 
significant proportion of pigmentary changes, striae gravidarum 
and specific dermatoses of pregnancy. Significantly higher 
proportion of vascular changes, striae gravidarum and specific 
dermatoses of pregnancy was observed in third trimester. 
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 PROFORMA 
Serial No 
Name 
Age 
Address 
Occupation 
Income 
Obstetric Status 
LMP 
EDD 
Trimester 
Antenatal H/O 
Dermatological complaints 
Onset of skin changes / lesions in relation to duration of pregnancy 
Exacerbating / Relieving factors 
H/O similar illness in previous pregnancies 
Treatment H/O 
Obstetric complaints 
Any other skin / medical diseases 
 
 DERMATOLOGICAL EXAMINATION 
A. PHYSIOLOGICAL 
I. Hyperpigmentation 
1. Linea nigra 
2. Melasma 
3. Diffuse pigmentation of areolae, nipples, abdomen and 
genitalia 
4. Naevi 
II. Vascular Changes 
1. Gingival hyperplasia 
2. Epulis of pregnancy 
3. Varicose veins 
4. Pedal edema 
5. Abdominal wall edema 
6. Capillary hemangioma 
7. Spider angiomas 
8. Palmar erythema 
III. Connective tissue 
1. Striae gravidarum 
2. Acrochordons 
IV. Changes in hair Growth 
1. Increased hair growth 
2. Hair loss 
V. Eccrine Glands 
1. Miliaria 
VI. Nails 
1. Brittleness of  Nail Plate 
2. Onycholysis 
3. Others if any 
B. DERMATOSES OF PREGNANCY 
I. Pruritus gravidarum 
II. Pruritic urticarial papules and plaques of pregnancy 
III. Prurigo of pregnancy 
IV. Pruritic folliculitis 
V. Pemphigoid gestationis 
C. DERMATOSES AND TUMOURS MODIFIED BY PREGNANCY 
I. Infections 
1. Bacterial 
2. Viral 
3. Fungal 
4. Protozoal 
5. Parasitic infestations       
II. Autoimmune disorder 
1. Lupus Erythematosus 
2. Systemic Sclerosis 
3. Dermatomyositis / Polymyositis 
III. Metabolic disorder 
1. Porphyria cutanea tarda 
2. Acrodermatitis enteropathica 
IV. Disorders of Connective tissue 
1. Ehlers – Danlos syndrome 
2. Pseudoxanthoma elasticum 
V. Tumors 
VI. Miscellaneous 
1. Acne vulgaris 
2. Insect bite allergy 
3. Psoriasis 
4. Impetigo herpetiformis 
5. Erythema multiforme 
6. Others, if any. 
INVESTIGATION 
1. Scraping for fungus & KOH mount examination 
2. Gram’s stain 
3. Tzanck smear 
4. Slit skin smear for AFB 
5. Blood sugar 
6. Complete hemogram  
7. Blood VDRL 
8. ELISA for HIV 
9. Liver function test for pruritus related diseases 
10. Skin biopsy 
11. Other relevant investigations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

KEY TO MASTER SHEET 
 
OS – Obstetric status 
TM –  Trimester 
LN –  Linea nigra 
ME –  Melasma 
PIG –  Diffuse pigmentation 
NV –  Naevi 
GH –  Gingival hyperplasia 
VA –  Varicosity  
PE –  Pedal edema 
AE –  Abdominal wall edema 
ST –  Striae gravidarum 
HA –  Hair changes 
NA –  Nail changes 
MR –  Miliaria rubra 
PrG –  Pruritus gravidarum 
PU –  Pruritic urticarial papules and plaques of pregnancy 
PP –  Prurigo of pregnancy 
PF –  Pruritic folliculitis of pregnancy 
PG –  Pemphigoid gestationis 
FU –  Furunculosis  
HD –  Hansen disease 
WA –  Wart  
HSV –  Herpes simplex 
HZ –  Herpes zoster 
HIV –  Human immunodeficiency virus 
CA –  Candidiasis 
TV –  Tinea versicolor 
DE –  Dermatophytosis 
TR –  Trichomoniasis 
SC –  Scabies 
AC –  Acne vulgaris 
IB –  Insect bite allergy 
AN –  Acanthosis nigricans 
PR –  Pityriasis rosea 
PS –  Psoriasis 
IH –  Impetigo herpetiformis 
SLE –  Systemic lupus erythematosus 
AP –  Antiphospholipid antibody syndrome 
NF –  Neurofibromatosis 
UR –  Urticaria 
+ –  Present 
- –  Absent 
  
 
 
 
 
 
 
 
 
 
